Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiqun Han

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Scientific Reports|March 5, 2022
Clinical outcomes and a nomogram for de novo metastatic breast cancer with lung metastasis: a population-based studyWeiming Liu, Yiqun Han
Science China. Life Sciences|May 31, 2015
Health effects of fine particles (PM2.5) in ambient airYiQun Han, Tong Zhu
Journal of Personalized Medicine|March 29, 2023
Cytotoxic Lymphocyte-Related Gene Signature in Triple-Negative Breast CancerYiqun Han, Jiayu Wang, Binghe Xu
Biomed Research International|June 14, 2021
Tumor Microenvironment Subtypes and Immune-Related Signatures for the Prognosis of Breast CancerYiqun Han, Jiayu Wang, Binghe Xu
Critical Reviews in Oncology/Hematology|June 4, 2021
Cutaneous adverse events associated with immune checkpoint blockade: A systematic review and meta-analysisYiqun Han, Jiayu Wang, Binghe Xu
Environment International|July 14, 2018
Association between birthweight and ambient PM<sub>2.5</sub> in the United States: Individually-varied susceptibility and spatial heterogeneityTao Xue, Tong Zhu, Yiqun Han
Journal of Cancer|January 6, 2021
Novel biomarkers and prediction model for the pathological complete response to neoadjuvant treatment of triple-negative breast cancerYiqun Han, Jiayu Wang, Binghe Xu
Breast (Edinburgh, Scotland)|September 26, 2020
Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysisYiqun Han, Jiayu Wang, Binghe Xu
Journal of Personalized Medicine|February 25, 2023
Prognostic Factors for Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant ChemotherapyZhijun Li, Yiqun Han, Jiayu Wang, et al.
Current Problems in Cancer|May 25, 2020
Comparative efficacy and safety of CDK4/6 and PI3K/AKT/mTOR inhibitors in women with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and network meta-analysisYiqun Han, Jiayu Wang, Zijing Wang, et al.
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Scientific Reports|March 5, 2022
Clinical outcomes and a nomogram for de novo metastatic breast cancer with lung metastasis: a population-based studyWeiming Liu, Yiqun Han
Science China. Life Sciences|May 31, 2015
Health effects of fine particles (PM2.5) in ambient airYiQun Han, Tong Zhu
Journal of Personalized Medicine|March 29, 2023
Cytotoxic Lymphocyte-Related Gene Signature in Triple-Negative Breast CancerYiqun Han, Jiayu Wang, Binghe Xu
Biomed Research International|June 14, 2021
Tumor Microenvironment Subtypes and Immune-Related Signatures for the Prognosis of Breast CancerYiqun Han, Jiayu Wang, Binghe Xu
Critical Reviews in Oncology/Hematology|June 4, 2021
Cutaneous adverse events associated with immune checkpoint blockade: A systematic review and meta-analysisYiqun Han, Jiayu Wang, Binghe Xu
Environment International|July 14, 2018
Association between birthweight and ambient PM<sub>2.5</sub> in the United States: Individually-varied susceptibility and spatial heterogeneityTao Xue, Tong Zhu, Yiqun Han
Journal of Cancer|January 6, 2021
Novel biomarkers and prediction model for the pathological complete response to neoadjuvant treatment of triple-negative breast cancerYiqun Han, Jiayu Wang, Binghe Xu
Breast (Edinburgh, Scotland)|September 26, 2020
Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysisYiqun Han, Jiayu Wang, Binghe Xu
Journal of Personalized Medicine|February 25, 2023
Prognostic Factors for Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant ChemotherapyZhijun Li, Yiqun Han, Jiayu Wang, et al.
Current Problems in Cancer|May 25, 2020
Comparative efficacy and safety of CDK4/6 and PI3K/AKT/mTOR inhibitors in women with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and network meta-analysisYiqun Han, Jiayu Wang, Zijing Wang, et al.
Pageof 11